Drug
Dutogliptin clinical trials
Also written PHX1149 and PHX1149T.
Includes 3 studies of Dutogliptin tartrate.
- studies test it
- 12
- open now
- 1
- in phase 3
- 9
- first study started
- 2007
Keep track of what changes. Save the dutogliptin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
12 studies that test it; most in 2009 (6)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 6 |
| 2010 | 1 |
| 2018 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
- Phase 3
- 9
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 0
Phenomix (7) · Forest Laboratories (3) · Recardio, Inc. (2)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses dutogliptin is read from its arms, and is right about nine times in ten.
Testing it · 12
- Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial InfarctionNot yet recruitingPhase 3Recardio, Inc.NCT05881382Written as Dutogliptin + Filgrastim
- Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial InfarctionCompletedPhase 2Recardio, Inc.NCT03486080Written as Dutogliptin Tartrate
- Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without MetforminTerminatedPhase 3Forest LaboratoriesNCT00947557Written as Dutogliptin
- Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With PioglitazoneTerminatedPhase 3Forest LaboratoriesNCT00970424Written as Dutogliptin
- Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone AloneTerminatedPhase 3Forest LaboratoriesNCT01089790Written as Dutogliptin
- Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes MellitusTerminatedPhase 3PhenomixNCT00865592Written as dutogliptin
- Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of MetforminTerminatedPhase 3PhenomixNCT00850239Written as dutogliptin
- Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of MetforminTerminatedPhase 3PhenomixNCT00998686Written as dutogliptin
- Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes MellitusTerminatedPhase 2PhenomixNCT01101945Written as dutogliptin
- Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes MellitusCompletedPhase 3PhenomixNCT00690638Written as PHX1149T
- Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal ImpairmentTerminatedPhase 3PhenomixNCT00958269Written as dutogliptin
- A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes MellitusStatus unknownPhase 2PhenomixNCT00482950Written as PHX1149T
Codes
What other systems call dutogliptin · ClinicalTrials.gg INT005704
- MeSH (NLM) C552164dutogliptinOne source NLM
- UNII (FDA) 38EAO245ZXDUTOGLIPTINConfirmed FDA, NLM, Wikidata
- Wikidata Q27256778dutogliptinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87492DutogliptinOne source FDA
- DrugBank DB11723One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C552164 | dutogliptin | One source NLM |
| UNII (FDA) | 38EAO245ZX | DUTOGLIPTIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27256778 | dutogliptin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87492 | Dutogliptin | One source FDA |
| DrugBank | DB11723 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.